Lorraine Harper

15.5k total citations · 2 hit papers
192 papers, 8.3k citations indexed

About

Lorraine Harper is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Lorraine Harper has authored 192 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Pulmonary and Respiratory Medicine, 59 papers in Rheumatology and 53 papers in Immunology. Recurrent topics in Lorraine Harper's work include Vasculitis and related conditions (127 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (46 papers) and Otitis Media and Relapsing Polychondritis (33 papers). Lorraine Harper is often cited by papers focused on Vasculitis and related conditions (127 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (46 papers) and Otitis Media and Relapsing Polychondritis (33 papers). Lorraine Harper collaborates with scholars based in United Kingdom, Sweden and Netherlands. Lorraine Harper's co-authors include Caroline O.S. Savage, David Jayne, Caroline O. S. Savage, Raashid Luqmani, Charles D. Pusey, Kirsten de Groot, Oliver Floßmann, Matthew D. Morgan, Kerstin Westman and Alfred Mahr and has published in prestigious journals such as The Lancet, JAMA and Nature Genetics.

In The Last Decade

Lorraine Harper

180 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term patient survival in ANCA-associated vasculitis

2010 641 citations Oliver Floßmann, Annelies E. Berden et al. profile →
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

2017 420 citations David Jayne, Annette Bruchfeld et al. Journal of the American Society of Nephrology profile →

Peers

Countries citing papers authored by Lorraine Harper

Since Specialization

Citations

This map shows the geographic impact of Lorraine Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Harper more than expected).

Fields of papers citing papers by Lorraine Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Harper. The network helps show where Lorraine Harper may publish in the future.

Co-authorship network of co-authors of Lorraine Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Harper. A scholar is included among the top collaborators of Lorraine Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Harper. Lorraine Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increasing the inclusivity of digital health co-production: an integrative review 2025 ·Frontiers in Digital Health ·Ian Litchfield, Gayathri Delanerolle, (unknown), (unknown), (unknown), Lorraine Harper	0
2	Screening for latent tuberculosis infection in patients with chronic kidney disease: a review of evidence and current practice in the UK 2025 ·Clinical Kidney Journal ·(unknown), Jyoti Baharani, (unknown), Lorraine Harper, Adam F. Cunningham, Martin Dedicoat, Matthew K. O’Shea	1
3	Understanding the influences on the design and delivery of an integrated child health and social care service in underserved communities in the UK: A qualitative exploration using the SELFIE framework 2025 ·Health Policy ·Ian Litchfield, Lorraine Harper, Muslim Abbas Syed, (unknown), (unknown), Charl C. Wolhuter, Chris Bird	1
4	P184 Geographical variations in delivery of intravenous treatments for ANCA-associated vasculitis 2024 ·Lara D. Veeken ·(unknown), Avril Nicoll, Louise Locock, Lorraine Harper, Mark A. Little, Neil Basu, Rosemary Hollick	0
5	P19 Our experience diagnosing and treating deficiency of adenine deaminase 2 (DADA2) vasculitis 2023 ·Rheumatology Advances in Practice ·(unknown), (unknown), Lorraine Harper	0
6	Cocaine-induced granulomatosis with polyangiitis—an under-recognized condition 2022 ·Rheumatology Advances in Practice ·(unknown), (unknown), (unknown), (unknown), Áine Burns, Sally Hamour, Ruth J. Pepper, (unknown), Dimitrios Chanouzas, Simon Gane, Alan D. Salama, Lorraine Harper	11
7	Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis 2019 ·The Journal of Rheumatology ·Maria Weiner, (unknown), Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, (unknown), Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	9
8	Treatment of fatigue with physical activity and behavioural change support in vasculitis: study protocol for an open-label randomised controlled feasibility study 2018 ·BMJ Open ·Lorraine Harper, Matthew D. Morgan, Dimitrios Chanouzas, (unknown), (unknown), Caroline Dean, Kate Fletcher, Fiona Cramp, Sheila Greenfield, Catherine A Hewitt, Natalie Ives, Sue Jowett, Amanda Daley	15
9	Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis breakdown → 2017 ·Journal of the American Society of Nephrology ·David Jayne, Annette Bruchfeld, Lorraine Harper, Matthias Schaier, Michael Venning, Patrick Hamilton, Volker Burst, Franziska Grundmann, Michel Jadoul, István Szombati, Vladimı́r Tesař, Mårten Segelmark, Antonia Potarca, Thomas J. Schall, Pirow Bekker, (unknown)	420
10	WS7_1 Organ Damage and Hospitalization in Elderly Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis 2017 ·Lara D. Veeken ·Maria Weiner, (unknown), Aladdin J Mohammad, Zdenka Hrušková, Anisha Tanna, P. Sharp, Amy Kang, Annette Bruchfeld, Daina Selga, (unknown), Kerstin Westman, Per Eriksson, Lorraine Harper, Charles D. Pusey, Vladimı́r Tesař, Alan D. Salama, Mårten Segelmark	11
11	Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis 2014 ·Nephrology Dialysis Transplantation ·David Jayne, Annette Bruchfeld, Matthias Schaier, Kazimierz Ciechanowski, Lorraine Harper, Michel Jadoul, Mårten Segelmark, Daina Selga, István Szombati, Michael Venning, (unknown), Christian Hugo, Paul Van Daele, Ondřej Viklický, Antonia Potarca, Thomas J. Schall, Pirow Bekker	4
12	Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis 2014 ·Lara D. Veeken ·Neil Basu, Andrew McClean, Lorraine Harper, E. Nicole Amft, Neeraj Dhaun, Raashid Luqmani, Mark A. Little, David Jayne, Oliver Floßmann, John McLaren, Винод Кумар, Lars P. Erwig, D M Reid, Gary J. Macfarlane, Gareth T. Jones	30
13	Cardiovascular Effects of Sevelamer in Stage 3 CKD 2013 ·Journal of the American Society of Nephrology ·Colin D. Chue, John Townend, William E. Moody, Daniel Zehnder, (unknown), Lorraine Harper, Nicola C. Edwards, Richard P. Steeds, Charles J. Ferro	92
14	Predictors and Consequences of Fatigue in Prevalent Kidney Transplant Recipients 2013 ·Transplantation ·Winnie Chan, Jos A. Bosch, David A. Jones, Okdeep Kaur, Nicholas Inston, (unknown), Andrew McClean, Philip G. McTernan, Lorraine Harper, Anna C. Phillips, Richard Borrows	35
15	Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV). 2012 ·Oxford University Research Archive (ORA) (University of Oxford) ·Neil Basu, Andrew McClean, Raashid Luqmani, Lorraine Harper, Oliver Floßmann, David Jayne, Mark A. Little, E. Nicole Amft, Neeraj Dhaun, (unknown), Veena Kumar, Lars P. Erwig, Gregory T. Jones, (unknown), Gary J. Macfarlane	1
16	Long-term survival of ANCA-associated vasculitis 2009 ·Apmis ·Oliver Floßmann, Annelies E. Berden, Kirsten de Groot, Lorraine Harper, Caroline Heijl, Peter Höglund, David Jayne, Raashid Luqmani, Alfred Mahr, Chetan Mukhtyar, C D Pusey, N Rasmussen, Kerstin Westman	3
17	Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial 2009 ·Lund University Publications (Lund University) ·Lorraine Harper, Kirsten de Groot, David Jayne, (unknown), Gina Gregorini, Wolfgang L. Gross, Raashid Luqmani, C. D. Pusey, Niels Rasmussen, R Sinico, Vladimı́r Tesař, (unknown), Kerstin Westman, (unknown)	6
18	Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro 2005 ·Pediatric Nephrology ·(unknown), Julie M. Williams, Lorraine Harper, Caroline O. S. Savage, Carol M. Taylor	6
19	Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: Relevance to systemic vasculitis 2003 ·Arthritis & Rheumatism ·(unknown), (unknown), Lorraine Harper, Mark T. Drayson, Caroline O. S. Savage	58
20	Vasculitis Sistémica Primaria 1998 ·SHILAP Revista de lepidopterología ·(unknown), Lorraine Harper, D. Adu	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact